» Articles » PMID: 22915354

Drug Safety Studies and Measures of Effect Using the Self-controlled Case Series Design

Overview
Publisher Wiley
Date 2012 Aug 24
PMID 22915354
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Core Concepts: Self-Controlled Designs in Pharmacoepidemiology.

Bots S, Brown J, Wong A, Martin I, Douglas I, Klungel O Pharmacoepidemiol Drug Saf. 2025; 34(1):e70071.

PMID: 39805806 PMC: 11729261. DOI: 10.1002/pds.70071.


Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England.

Copland E, Patone M, Saatci D, Handunnetthi L, Hirst J, Hunt D Nat Commun. 2024; 15(1):3822.

PMID: 38802362 PMC: 11130197. DOI: 10.1038/s41467-024-47745-z.


Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study.

Morciano C, Spila Alegiani S, Ippolito F, Belleudi V, Trifiro G, Zanoni G PLoS One. 2024; 19(1):e0290879.

PMID: 38241309 PMC: 10798452. DOI: 10.1371/journal.pone.0290879.


Postmarketing observational study on the safety of 2021/2022 and 2022/2023 influenza vaccination campaigns in Italy: TheShinISS-Vax|Flu study protocol.

Spila Alegiani S, Morciano C, Menniti-Ippolito F, Da Cas R, Felicetti P, Marchione P BMJ Open. 2023; 13(8):e069858.

PMID: 37550029 PMC: 10407352. DOI: 10.1136/bmjopen-2022-069858.


Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England.

Nafilyan V, Bermingham C, Ward I, Morgan J, Zaccardi F, Khunti K Nat Commun. 2023; 14(1):1541.

PMID: 36973247 PMC: 10043280. DOI: 10.1038/s41467-023-36494-0.